A trend in favor of upregulation of CD44 in bone metastatic PCa, but not relapsed PCa, relative to primary PCa was observed (Fig. 7B; right panel), even though statistical significance was not reached, possibly due to the low sample size (n = 10). Here, CD44 is linked to posterior cortical atrophy.